BamSEC and AlphaSense Join Forces
Learn More

Allergan Plc

Formerly NYSE: AGN
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.3
from DEFA14A 17 pages Expenses Reimbursement Agreement Dated as of June 25, 2019 Between Abbvie Inc. and Allergan Plc
12/34/56
EX-2.3
from 8-K 17 pages Expenses Reimbursement Agreement Dated as of June 25, 2019 Between Abbvie Inc. and Allergan Plc
12/34/56
EX-2.2
from 8-K 7 pages Appendix III Conditions of the Acquisition and the Scheme
12/34/56
EX-2.2
from DEFA14A 7 pages Appendix III Conditions of the Acquisition and the Scheme
12/34/56
EX-2.1
from 8-K 103 pages Transaction Agreement Dated as of June 25, 2019 Among Abbvie Inc. Venice Subsidiary, LLC and Allergan Plc
12/34/56
EX-2.1
from DEFA14A 103 pages Transaction Agreement Dated as of June 25, 2019 Among Abbvie Inc. Venice Subsidiary, LLC and Allergan Plc
12/34/56
EX-2.4
from 8-K 2 pages Teva Pharmaceutical Industries Ltd. 5 Basel Street Petach Tikva 4951033 Israel Attention: Richard S. Egosi, Chief Legal Officer Re. Extension of Outside Date Dear Mr. Egosi
12/34/56
EX-2.3
from 8-K 4 pages Third Amendment to Master Purchase Agreement
12/34/56
EX-2.2
from 8-K 5 pages Second Amendment to Master Purchase Agreement
12/34/56
EX-2.1
from 8-K 6 pages First Amendment to Master Purchase Agreement
12/34/56
EX-2.1
from 425 141 pages Agreement and Plan of Merger by and Among Pfizer Inc., Allergan PLC and Watson Merger Sub Inc. Dated as of November 22, 2015
12/34/56
EX-2.1
from 8-K 141 pages Agreement and Plan of Merger by and Among Pfizer Inc., Allergan Plc and Watson Merger Sub Inc. Dated as of November 22, 2015
12/34/56
EX-2.2
from 10-Q 136 pages +++ Master Purchase Agreement Dated as of July 26, 2015 by and Between Allergan Plc and Teva Pharmaceutical Industries Ltd
12/34/56
EX-2.1
from 8-K 108 pages Amended and Restated Agreement and Plan of Merger by and Among Allergan Plc, Keto Merger Sub, Inc. and Kythera Biopharmaceuticals, Inc. Dated as of August 4, 2015
12/34/56
EX-2.1
from 425 108 pages Amended and Restated Agreement and Plan of Merger by and Among Allergan PLC, Keto Merger Sub, Inc. and Kythera Biopharmaceuticals, Inc. Dated as of August 4, 2015
12/34/56
EX-2.1
from 8-K 135 pages Master Purchase Agreement Dated as of July 26, 2015 by and Between Allergan Plc and Teva Pharmaceutical Industries Ltd
12/34/56
EX-2.1
from 425 5 pages Amendment No. 1 to Agreement and Plan of Merger
12/34/56
EX-2.1
from 8-K 5 pages Amendment No. 1 to Agreement and Plan of Merger
12/34/56
EX-2.1
from 8-K 109 pages Agreement and Plan of Merger by and Among Allergan Plc, Keto Merger Sub, Inc. and Kythera Biopharmaceuticals, Inc. Dated as of June 17, 2015
12/34/56
EX-2.1
from 425 109 pages Agreement and Plan of Merger by and Among Allergan PLC, Keto Merger Sub, Inc. and Kythera Biopharmaceuticals, Inc. Dated as of June 17, 2015
12/34/56